Initial clinical trials with a tubless lithotriptor
| Autor: | Lawrence S. Ross, L. Paul Sonda, Stewart Lipson |
|---|---|
| Rok vydání: | 1990 |
| Předmět: |
medicine.medical_specialty
Ureteral Calculi business.industry Urology medicine.medical_treatment Proximal ureter Lithotripsy Surgery Clinical trial Food and drug administration Kidney Calculi medicine.anatomical_structure Multicenter study Single site Fragmentation rate medicine Humans business Renal pelvis |
| Zdroj: | The Journal of urology. 143(1) |
| ISSN: | 0022-5347 |
| Popis: | The Medstone 1050 is a new tubless lithotriptor developed in the United States. Under Food and Drug Administration guidelines a human treatment protocol has been developed. The first 50 patients treated at a single site and followed for a minimum of 3 months are presented. All stones treated were 3cm. or less in longest dimension and located in the renal pelvis, calices or proximal ureter. An adequate fragmentation rate of 90% was achieved in this group. There were no significant complications in any patient. A larger multicenter study presently is underway. (J. Urol, 143: 10-12, 1990) |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|